Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical BMT with Flu/Bu/TBI and Post-Transplant Cyclophosphamide
NCT01749293Phase 2Terminated
- Sponsor
- University of Illinois Chicago
- Start
- Aug 2012
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, busulfan, cyclophosphamide in hematologic malignancy, sponsored by University of Illinois Chicago. Started Aug 2012; status: terminated.
02
Drugs
fludarabinebusulfancyclophosphamide
03
Conditions
hematologic malignancy
Beyond the preview
Go deeper on NCT01749293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01749293.